Blog - Page 3180 of 5756

MondayDec 10, 2012 11:12 am

Timberline Resources Corp. (TLR) on Target for Mid-2013 Gold Production near Butte, Montana

Timberline Resources, the domestic precious mineral developer focused on a portfolio of properties in Idaho, Montana, and Nevada, which holds a 50% carried interest ownership stake in the highly prospective Butte Highlands Gold Project in Montana, reported today that the company has received the necessary draft Hard Rock Operating Permit and Compliance Determination for Butte Highlands from the Montana Department of Environmental Quality (MDEQ). This essentially validates that the operating permit application meets all Metal Mine Reclamation Act requirements, meaning that TLR is a shoe-in to receive the final Hard Rock Operating Permit on time to meet the projected mid-2013…

MondayDec 10, 2012 7:47 am

VuMee, Inc. (VUME) Picks Up New Content Providers

VuMee announced that the company has taken on three new celebrity content providers: comedians Dexter Tucker and Guy Torry, as well as former Tennessee Titans and Philadelphia Eagles NFL star Jevon Kearse. The celebrities will be connecting with fans via VuMee’s technology. VuMee is a digital advertising platform that is focused on bringing brands and personalities to consumers through video content. VuMee targets specific consumer segments to bring users media from companies, brands, and celebrities on PC and mobile platforms. Guy Torry, a standup comic who has toured with the national Kings of Comedy show, has also guest-starred on TV…

MondayDec 10, 2012 7:47 am

GNCC Capital, Inc. (GNCP) is “One to Watch”

GNCC Capital is dead set on proving up reserves through shrewdly directed exploration on the company’s six main properties in Arizona, three of which are gold-focused and three of which are silver-focused, with about an 80-20 mix percentage-wise for gold-silver overall. The company has considerable development guidance in the form of previous documentation on the properties, as well as a clear vision for the necessary analytical work including surveying, sampling, and drilling towards production. Heavy emphasis on developing the historically well-documented mineral potential at the gold sites in particular is a key objective for GNCP, and the company has taken…

MondayDec 10, 2012 7:41 am

Bioanalytical Systems, Inc. (BASI) to Collaborate with DSI on Groundbreaking New Study

Friday, Bioanalytical Systems announced a collaboration with Data Sciences International (DSI) to conduct a pioneering study that combines Bioanalytical Systems’ Culex-L automated sampling system with PhysioTel Digital, DSI’s latest large animal telemetry technology. DSI is a biomedical research company with its focus on preclinical systems physiology and pharmacology. In this groundbreaking study, BASi’s Culex-L automated in vivo sampling system will simultaneously gather biological samples at pre-programmed intervals while DSI telemetry devices collect heart rate, blood pressure, and other cardiovascular data. The gathering of these various types of data formerly required two separate experiments and allowed only discontinuous data collection. Combining…

FridayDec 07, 2012 2:39 pm

TG Therapeutics, Inc. (TGTX) Initiates Clinical Trial to Evaluate TG-1101, Lenalidomide Combination

Clinical-stage biopharm company TG Therapeutics today announced that it has initiated a phase I/II trial to evaluate the safety, tolerability, and efficacy of TG-1101, the company’s novel third-generation anti-CD20 monoclonal antibody, in combination with lenalidomide (Revlimid®) for patients with relapsed or refractory B-cell lymphoid malignancies who were previously treated with anti-CD20 antibody therapy. This 30-patient multi-center trial is TG Therapeutics’ second clinical trial of TG-1101 in North America; the company in September began enrollment of its on-going phase I/II trial with single agent TG-1101 in patients with Non-Hodgkin’s Lymphoma (NHL). TG-1101 has displayed high single agent activity in a phase…

FridayDec 07, 2012 11:35 am

Fundamental Research Corp. Highlights the Strong Prospects of Lomiko Metals Inc. (LMR.V)

Lomiko Metals, a Surrey British Columbia based junior mining company, was recently the focus of a research report released earlier this week. The investment highlights included information regarding the 2012 drilling on the Quatre Milles graphite property, the acquisition of the Quatre Milles land package, soil sampling on the company’s Vines Lake property, additions to the Board of Advisors, and key financial information. Quatre Milles Graphite Property In January 2012, Lomiko Metals entered into an agreement to acquire a 100% interest in the Quatre Milles graphite property, located in south-western Quebec. The company commenced a two-phase drill program from August…

FridayDec 07, 2012 11:34 am

Novatel Wireless Inc. (NVTL) Video Chart for Friday, December 7, 2012

NVTL made a 30% climb off a bottom at $1.17 late in November. After a quick retracement, shares rose significantly on Thursday with a move of 8.8%, putting this chart on radar for continued upward pressure towards initial resistance at $1.45. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts Let us hear your thoughts below:

FridayDec 07, 2012 11:34 am

USA Graphite, Inc. (USGT) Spammed Aggressively

We have observed emails spamming USA Graphite. Investors should be wary of these emails, as they are completely anonymous and violate the CAN-SPAM Act established by the FTC. As of this time, the company has not provided a public comment on the issue. Stocks to avoid, due diligence, monitoring investments, key terms in investing and other related topics are covered by us in our Market Basics section. Here we give answers to basic questions regarding stock investments for both new and experienced investors. To view our Market Basics page, visit www.basics.qualitystocks.net. QualityStocks also helps protect investors by rating thousands of…

FridayDec 07, 2012 11:33 am

International Stem Cell Corp. (ISCO) Stands to Benefit from a German Court Decision

International Stem Cell Corp., a biotech company specializing in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products, today told investors of the recent decision by the German Federal Court of Justice, in the Greenpeace vs Brüstle patent case, which may allow the company to take a leading position in the European market. This important ruling strengthens ISCO’s position that parthenogenetic technology may be an acceptable method of producing banks of human pluripotent stem cell (hpSC) lines and derivatives for the commercial therapeutic markets in Europe. As a result…

FridayDec 07, 2012 7:28 am

Cytomedix, Inc. (CMXI) Partners with National Institute of Health to Conduct First-of-its-Kind Clinical Trial

Cytomedix, a regenerative therapies company focused on the development of innovative platelet and adult stem cell technologies, has inked an agreement with the National Institute of Health (NIH) to collaborate on a phase 2 clinical study of patients with intermittent claudication (IC), a condition that causes reduced flow of blood and oxygen to muscles in the leg. The study is being funded by the National Heart, Lung and Blood Institute/NIH, and will be managed by the Cardiovascular Cell Therapy Research Network (CCTRN), which will also assume responsibility for patient enrollment. The phase 2 PACE (Patients with Intermittent Claudication Injected with…

Site Search

Company Search